Case 2: Ulcerative Colitis Patient on an Anti-TNF Experiences Recurrence of Symptoms
Patients with ulcerative colitis (UC) often receive inadequate or inappropriate treatment. Management of UC is based on the assessment of disease activity, which is represented by both clinical symptoms and mucosal inflammation. This Virtual Practice has been developed to simulate the day-to-day challenges encountered by clinicians who provide care to patients with UC.
Medium: Virtual e-learning module
Commercial Support Statetements: Support for this activity has been provided through educational grants from Janssen Biotech, Inc, administered by Janssen Scientific Affairs and Takeda Pharmaceuticals International, U.S. Region.
Joint Provider: RedMedEd
This activity has been designed to meet the educational needs of gastroenterologists and other health care professionals who are involved in the management of patients with UC.
Upon completion of this activity, participants should be able to:
- Discuss the efficacy, safety, and clinical placement of new and emerging therapies for UC;
- Design effective strategies for managing UC that take into consideration the indications, risks, and benefits of long-term nonbiologic and biologic therapies.
David T. Rubin, MD—Program Chair
Joseph B. Kirsner Professor of Medicine
Chief, Section of Gastroenterology, Hepatology and Nutrition
Co-Director, Digestive Diseases Center
University of Chicago Medicine
Christina Y. Ha, MD
Clinical Assistant Professor
Division of Digestive Diseases
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, California
Kian Keyashian, MD
Assistant Professor of Medicine
Division of Gastroenterology
Oregon Health & Science University
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and RedMedEd. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.